Fort Lee, New Jersey, USA, Oct. 16, 2014 (GLOBE NEWSWIRE) -- Herborium® Group,
Inc.(OTC Pink: HBRM),
www.Herborium.com, a
Botanical Therapeutics® Company and the provider of unique
all botanical medicines (Botanical Therapeutics®)
announced today that its Third Quarter sales for 2014 grew
105% over the same quarter in 2013
In addition, the company cited the following results that marked
a successful completion of the Third Quarter.
§ The Company's gross profit in 3rd Quarter
2014 increased to 80% over the same period in 2013
§ The loss from operations in Third Quarter of 2014 was
cut in half compared with the Third Quarter of 2013
§ Sales for the first three Quarters of 2014 are 31%
higher than ENTIRE 2013 annual sales
§ Herborium's Facebook "likes" approached 10,000 which
represents another 10% increase compared with just the
previous quarter Q2 2014.
"The Company's growth continues and we look forward to
maintaining our successful path to accelerating time to market and
profitability and in the development of novel natural
medicines-Botanical Therapeutics®". Commented Dr. Agnes P.
Olszewski, CEO and Chiarwoman of Herborium Group.
About Herborium Group,
Inc.
Herborium Group, Inc., a botanical therapeutics® company that
develops, license and markets proprietary, botanical based
medicinal products to consumers and healthcare professionals. The
Company business model focuses on emerging market opportunities
spearheaded by the growth of a new market sector located between
high-cost, high-risk, ethical pharmaceuticals and commoditized
classic nutraceuticals (supplements). The Company uses
clinical validation and a proactive regulatory strategy based on
the FDA Guidance for Industry: Botanical Drug Products
(FDA Guidance 2004) to establish and maintain a
differential advantage. Herborium has secured a pipeline of
botanical ingredients based products in the areas of dermatological
needs, wellness and energy, prostate health, women's health and
selected sexual disorders resulting from cardiovascular disease,
use of anti-depressants, diabetes, surgical procedures, and other
problems. Herborium Group sells its products in the United States,
the United Kingdom, and continental Europe through a network of
distributors, specialty retailers, and e-commerce. For more
information, please visit www.herborium.com, and www.acnease.com.
Safe Harbor Statement: This release contains
forward-looking statements with respect to the results of
operations and business of Sunrise Consulting Group, Inc., which
involves risks and uncertainties. The Company's actual future
results could materially differ from those discussed.
The Company intends that such statements about the Company's future
expectations, including future revenues and earnings, and all other
forward looking statements be subject to the "Safe Harbors"
provision of the Private Securities Litigation Reform Act of
1995.
CONTACT: Email: InvestorsRelations@Herborium.com
Customerservice@herborium.com
+201.849.4431
